Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
also known as G-868
Cariprazine is approved for schizophrenia and bipolar disorder
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidin-2(1H)-one compound with 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2
) protects mouse livers of the K18 Arg90Cys-overexpressing transgenic mice from Fas-induced apoptosis
Bilastine - CAS# 202189-78-4 enzyl)-N2 N2-dimethyl-N1-(pyridin-2-yl)ethane-1 2-diamine hydrochloride also known as G-868Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives). It exerts its effect as a selective histamine H1 receptor antagonist, and has a potency similar to cetirizine and is superior to fexofenadine. It was developed in Spain by FAES Farma. Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but
US$ 106.92
US$ 243.00
US$ 158.32
US$ 113.50
US$ 113.50
US$ 1341.50